Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Mokari Atabak. Director active across 1 company, notably CORCEPT THERAPEUTICS INC. Aggregated, 43 disclosures have been logged. Split: 0 buy · 22 sells. Total volume traded: €13.5m. Activity tracked since 1 September 2022. The latest transaction was disclosed on 30 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mokari Atabak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Mokari Atabak is Chief Financial Officer at CORCEPT THERAPEUTICS INC. He has 29 filings in total, and in the sampled recent filings from 2022-09-06 to 2026-07-17, sales amount to EUR 5477739 and the modal transaction nature is Attribution.